Showing results (891-900 of 1,115) with videos related to

Sort By:
Pageof 112
Plos Biology|December 12, 2017
Correction: Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer TherapyWeiqin Lu, Yumin Hu, Gang Chen, et al.
Plos Biology|May 17, 2012
Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapyWeiqin Lu, Yumin Hu, Gang Chen, et al.
Endocrinology|September 27, 2012
Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, β-cell dysfunction, and diabetesHeshan Peiris, Ravinarayan Raghupathi, Claire F Jessup, et al.
Cancer|December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaSusan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.
Blood|July 5, 2011
Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemiaXavier C Badoux, Michael J Keating, Sijin Wen, et al.
Scientific Reports|November 14, 2015
Quantification of tumor fluorescence during intraoperative optical cancer imagingRyan P Judy, Jane J Keating, Elizabeth M DeJesus, et al.
Blood|August 16, 2008
Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Jeffrey L Jorgensen, et al.
Blood|May 6, 2009
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experienceConstantine S Tam, Tait D Shanafelt, William G Wierda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2010
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progressionJoan H Admirand, Ronald J Knoblock, Kevin R Coombes, et al.
European Journal of Medicinal Chemistry|September 1, 2009
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agentsSuzanne M Cloonan, John J Keating, Stephen G Butler, et al.
Pageof 112